A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE study

Abstract

The difference between IV and IM routes of administration of widow spider antivenom is, at best, small and does not justify routinely choosing one route over the other. Furthermore, antivenom may provide no benefit over placebo.